SEB Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102M Buy
1,185,830
+3,194
+0.3% +$284K 0.38% 39
2026
Q2
$107M Sell
1,182,636
-187,566
-14% -$15.7M 0.4% 40
2026
Q1
$110M Buy
+1,370,202
New +$113M 0.47% 36

Other funds holding EW

SEB Asset Management's EW Position: Q3 2026 in Review

SEB Asset Management increased its Edwards Lifesciences (EW) stake by 0.27% in Q3 2026, buying an estimated $284K and bringing the position to 1,185,830 shares worth $102M. The position accounts for 0.38% of the portfolio, ranked #39.

SEB Asset Management first reported a position in EW in Q1 2026 and has held it in 3 quarters since. The position peaked at $110M in Q1 2026. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • SEB Asset Management held 1,185,830 shares of Edwards Lifesciences worth $102M as of Q3 2026.
  • SEB Asset Management bought 3,194 Edwards Lifesciences shares in Q3 2026, an estimated $284K.
  • Edwards Lifesciences made up 0.38% of SEB Asset Management's portfolio in Q3 2026, its #39 holding.
  • SEB Asset Management first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's Edwards Lifesciences position peaked at $110M in Q1 2026.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.